BrainsWay (Nasdaq:BWAY) announced plans for two new feasibility trials evaluating its neurostimulation technology. The studies both involve BrainsWay’s patented rotational field TMS (or Deep TMS 360°). The company’s transcranial magnetic stimulation (TMS) method of stimulation enables the activation of more neurons in the brain. With the new rotational field system under evaluation, two orthogonal TMS […]
Brainsway
BrainsWay has positive data for its deep transcranial magnetic stimulation tech
BrainsWay (Nasdaq:BWAY) today announced new real-world, post-market data demonstrating the efficacy of its brain stimulation technology. The data supports the use of BrainsWay’s accelerated deep transcranial magnetic stimulation (Deep TMS) for treating major depressive disorder (MDD). Results were published in the peer-reviewed journal Psychiatry Research. Deep TMS uses specially designed H-coils to stimulate deep and broad cortical […]
BrainsWay launches study program to evaluate neurostim tech
BrainsWay (Nasdaq:BWAY) announced today that it launched an investigator-initiated study (IIS) program for its Deep TMS technology. The company designed the program to support further research for Deep TMS (transcranial magnetic stimulation) by the clinical research community. According to a news release, BrainsWay plans to utilize data collaboration and equipment loan initiatives. The company accepts […]
BrainsWay scores coverage win on neurostim treatment for OCD
BrainsWay announced today that Cigna is offering positive coverage for its neurostimulation treatment of obsessive-compulsive disorder (OCD). Cigna provides commercial health coverage to approximately 17 million members in 13 states. It has Medicare Advantage plans in 16 states and is part of the Health Insurance Marketplace online exchange. It joins Centene, Highmark, Health Care Services […]
BrainsWay raises more than $45M
BrainsWay recently announced that it closed an underwritten public offering worth approximately $45.2 million in proceeds. The non-invasive brain disorder treatment developer offered more than 5.3 million American Depositary Shares (ADSs), upsized to include 693,300 ADSs sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares at $8.50 per share, […]
Former Dynatronics CEO to take corner office at BrainsWay
Neuromodulation therapy developer BrainsWay (NSDQ:BWAY) announced that it appointed former Dynatronics CEO Christopher von Jako as president and CEO. The company’s board of directors said von Jako, who will assume the role in January 2020, will be central to Brainsway’s strategic transition to U.S.-based leadership. Prior to his role as CEO of Dynatronics, von Jako served […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal year. We […]
BrainsWay touts results of dTMS study for depression
BrainsWay (NSDQ:BWAY) said today that a study shows that deep transcranial magnetic stimulation (dTMS) plus standard medication was significantly more effective at reducing depression levels among major depressive disorder (MDD) patients than standard medication alone. Researchers at the Psychiatric Hospital Sveti Ivan in Croatia conducted the 228-patient randomized controlled study independent of industry support. The […]
Brainsway prices downsized $28m IPO
Brainsway yesterday priced its initial public offering in the U.S. slightly below the terms it set earlier this month. The Jerusalem-based company, which is already publicly traded in Israel, said April 3 that it planned to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is would represent two ordinary shares, slated […]
Brainsway sets terms for $30m IPO
Brainsway this week set the terms on its forthcoming initial public offering in the U.S., saying it hopes to raise nearly $30 million. The Jerusalem-based company, which developed a transcranial magnetic stimulation device to treat psychological disorders, said it plans to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is slated […]
Brainsway registers for $30m IPO
Brainsway has registered for an upcoming initial public offering, looking to bring in $30 million to support its transcranial magnetic stimulation tech, according to a recently posed SEC filing. The Israel-based company said that it plans to list on the Nasdaq Global Market under the symbol “BWAY,” according to the filing. Brainsway develops and supports […]
